Archived Grant Opportunity View - GO3551
Medical Research Future Fund (MRFF) Frontier Health and Medical Research Program Stage One - Research Plan
The MRFF Frontier Health and Medical Research Program will provide grants to a total of $570 million over ten years to establish this landmark initiative. For the Stage One – Research Plan grant opportunity, up to $1 million in funding will be made available to 10 multi-disciplinary teams including research and industry partners to work on novel and transformative ideas that will produce practical benefits to Australians and also globally.
The teams will have 12 months to develop a detailed research plan to outline the activities, methods and partnerships required to transform the idea from concept to implementation in the health system.
Australia has the potential to lead markets and create new ones by applying cutting-edge science and technologies to new, first-in-world applications that improve human health. This program encourages Australia’s best and brightest researchers to create talented and ambitious multi-disciplinary teams.
The program will operate using a two-stage competitive process:
- Stage One funds the development of detailed research plans for cutting-edge research projects.
- Stage Two will fund the implementation of selected research projects.
Plans developed in Stage One are used to apply for implementation funding made available through Stage Two.
Stage One applications will open 30 January 2020.
Stage Two is currently closed.
To be eligible you must:
- have an Australian business number (ABN)
- be incorporated in Australia
You must also be one of the following eligible bodies:
- a medical research institute
- a university
- a corporate Commonwealth entity
- a corporation (including businesses and not for profits)
- a state or territory government
- a state or territory government entity
$10,000,000.00
From $250,000.00 to $1,000,000.00
To apply, go to: https://www.business.gov.au/fhmr
business.gov.au provides information and advice to businesses via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.